CNTB (Connect Biopharma Holdings) Other Current Receivables: $2.70 Mil (As of Mar. 2026)


CNTB Connect Biopharma Holdings Ltd CNTB
7 GF Score
Price $2.52
! 3 Warning Signs
View Full Analysis

What is Connect Biopharma Holdings Other Current Receivables?

Connect Biopharma Holdings CNTB -5.82% 7 Other Current Receivables is $2.70 Mil as of Mar. 2026. GuruFocus rates CNTB with a GF Score™ of 7/100. The stock has 3 warning signs investors should review.

Connect Biopharma Holdings's Other Current Receivables for the quarter that ended in Mar. 2026 was $2.70 Mil.

Connect Biopharma Holdings's quarterly Other Current Receivables declined from Sep. 2025 ($0.16 Mil) to Dec. 2025 ($0.15 Mil) but then increased from Dec. 2025 ($0.15 Mil) to Mar. 2026 ($2.70 Mil).

Connect Biopharma Holdings's annual Other Current Receivables declined from Dec. 2023 ($0.35 Mil) to Dec. 2024 ($0.26 Mil) and declined from Dec. 2024 ($0.26 Mil) to Dec. 2025 ($0.15 Mil).

Connect Biopharma Holdings Other Current Receivables Related Terms

Connect Biopharma Holdings Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Connect Biopharma Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Connect Biopharma Holdings Other Current Receivables Chart

Connect Biopharma Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 7.41 0.23 0.35 0.26 0.15

Connect Biopharma Holdings Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.19 0.16 0.15 2.70
CNTB
7GF Score
Connect Biopharma Holdings Ltd CNTB
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Connect Biopharma Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $2.70 Mil mean?
Connect Biopharma Holdings (CNTB) has a Other Current Receivables of $2.70 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Connect Biopharma Holdings and its competitors.
Is Connect Biopharma Holdings' Other Current Receivables too high?
Connect Biopharma Holdings' current Other Current Receivables is $2.70 Mil. Overall, Connect Biopharma Holdings has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Connect Biopharma Holdings' Other Current Receivables compare to ENLV and SMNR?
Connect Biopharma Holdings' Other Current Receivables of $2.70 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Connect Biopharma Holdings and its competitors. Connect Biopharma Holdings's current Other Current Receivables is $2.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Connect Biopharma Holdings stock overvalued right now?
Connect Biopharma Holdings (CNTB) has a current Other Current Receivables of $2.70 Mil. The current Other Current Receivables is $2.70 Mil. Connect Biopharma Holdings' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Connect Biopharma Holdings (CNTB), the current Other Current Receivables is $2.70 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Connect Biopharma Holdings Business Description

Address 3580 Carmel Mountain Road, Suite 200, San Diego, CA, USA, 92130
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
7GF Score

Get the complete analysis for CNTB

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.52
Price